Projects per year
- 1 - 50 out of 116 results
Search results
-
Active
-
-
-
Structural and functional alterations in mitochondria of patients with multi-organ injury and sepsis
Gotur, D. B., Hamilton, D. J. & Mylonakis, E.
4/3/24 → …
Project: Clinical Trial
-
Dysfunctional High Density Lipoprotein Free Cholesterol Bioavailability and Atherogenesis
Pownall, H. J., Gillard, B. K., Nasir, K., Patel, K. V. & Rosales, C.
3/21/24 → …
Project: Clinical Trial
-
-
A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species
Grimes, K. A., Lin, J., Malik, A. I. & Nigo, M.
11/16/23 → …
Project: Clinical Trial
-
Specialty societies advancing adult immunizations in patients with diabetes
10/1/23 → 9/30/25
Project: Federal Funding Agencies
-
A transformative platform to combat antibiotic resistant bacteria.
9/26/23 → 9/25/28
Project: Federal Funding Agencies
-
PK-RNN-V - Deep-Learning Based Pharmacokinetic Model for Vancomycin
9/21/23 → 7/31/28
Project: Federal Funding Agencies
-
De-labeling Penicillin Allergy in an Academic Medical Center ? A Quality Improvement Initiative
9/1/23 → 12/31/24
Project: Non Profit
-
-
MRWeight: Medical Residents Learning Weight Management Counseling Skills -- A Multi-Modal, Technology-Assisted, Spaced Education Program
5/2/23 → 2/29/28
Project: Federal Funding Agencies
-
Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol
4/4/23 → 2/28/27
Project: Federal Funding Agencies
-
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Ganguly, S., Mai, H. P., Petkova, J., Pingali, S. R. & Shah, S.
3/30/23 → …
Project: Clinical Trial
-
Subproject 2: Identification of Pathways that Can be Targeted for the Development of Novel Therapies for MRSA
3/1/23 → 1/31/27
Project: Federal Funding Agencies
-
Emergence of TonB-dependent receptor mediated cefiderocol resistance among multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates.
1/20/23 → 12/31/24
Project: Federal Funding Agencies
-
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study
Abdelrahim, M., Connor, A. A., Ghobrial, R. M., Gibbs, J. M., Graviss, E. A., Gupta, N., Kodali, S., Mobley, C. M., Moore, L. W., Rizk, E., Saharia, A., Singh, M. & Victor, III, D. W.
1/18/23 → …
Project: Clinical Trial
-
2023 ACS Prevention & Screening Project Recruitment Colon Cancer
1/1/23 → 12/31/24
Project: Non Profit
-
Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics.
Shafi, T.
9/7/22 → 4/30/25
Project: Federal Funding Agencies
-
Vaccination Responses in Lung Transplant Recipients
8/5/22 → 7/31/27
Project: Federal Funding Agencies
-
POR and Training Program on Multidrug-Resistant Organisms
7/1/22 → 6/30/26
Project: Federal Funding Agencies
-
Combining Transcutaneous Spinal Stimulation and Exoskeleton Training in the Rehabilitation of Spinal Cord Injury.
Sayenko, D., Kaldis, T. & Tabatabai, L. S.
6/20/22 → …
Project: Clinical Trial
-
VENOUS: A translational study of enterococcal bacteremia
6/1/22 → 5/31/25
Project: Federal Funding Agencies
-
Early Detection of Hepatocellular Carcinoma - Renewal Submission
4/21/22 → 2/28/27
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/25
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/25
Project: Federal Funding Agencies
-
-
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients with Clazakizumab
9/14/21 → 6/30/25
Project: Federal Funding Agencies
-
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
9/1/21 → 7/31/25
Project: Federal Funding Agencies
-
-
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable Hepatocellular Carcinoma Patients
Ghobrial, R. M., Abdelrahim, M. & Kodali, S.
4/1/21 → 3/31/26
Project: Federal Funding Agencies
-
-
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B., Chen, S., Niravath, P. A., Rosato, R. R. & Xu, S.
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
-
Defining the altered FUS-PARP-1-DNA Ligase III axis and its implications to nuclear and mitochondrial genome damage response in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Hegde, M., Hamilton, D. J., Horner, P. J. & Mitra, J.
4/15/20 → 3/31/25
Project: Federal Funding Agencies
-
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
3/26/20 → 3/25/45
Project: Non Profit
-
-
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
Pownall, H. J., Rosales, C. & Gillard, B. K.
12/1/19 → 11/30/24
Project: Federal Funding Agencies